Seven NBA stars returning from injury for 2026-27: Who is worth the bet, who is just a name to read out

I sat in the third row of a training facility in Dallas, on a September 2026 morning. Kyrie Irving entered the court at 7:40, took exactly 200 shots, then stopped at 9:15 — not a minute more. The strength coach beside me wrote two words on his board: "Full go." I wrote three different words in my notebook: "Full go, but." Behind his two words is a 2026-27 season waiting to be priced; behind my three words are seven names the entire fantasy world is lining up to buy. Seven names. Seven medical clearance slips. And one question nobody wants to ask out loud: you are coming back — but coming back for how many games? JFK airport taught me one thing: to get through the gate fast, don't stand in line. Over 34 years of reporting, I learned that what decides a player's value isn't the highlight reel but the schedule — who plays, who sits. This 2026-27 season, the whole story fits into a single variable: games played. In September 2026, the NBA market opened with a paradox. Seven stars — Kyrie Irving, Tyrese Haliburton, Damian Lillard, Ja Morant, Fred VanVleet, Zach Edey, Walker Kessler — all returning after missing between 62 and 82 games last season. Seven men, seven severe injuries, and a nearly full blank season for each. That detail is the entire story. The fantasy rankings this season read like an indictment written in the past tense. Irving posted nine straight Top-20 seasons. Haliburton finished Top 14 three years running, never falling below 22nd in 8-category formats since arriving in Indiana — a rare level of stability for a lead guard. VanVleet was once Top 30 for five seasons. All those numbers are true, and all of them belong to the time before their Achilles, ligaments and ankles were cut open. This is where I separate two things the crowd blends together: real competitive value and fantasy value. A Top-20 per-game player who only plays 55 games is worth roughly a Top-50 season asset. None of these seven has had a full season recently. Yet the market still prices them as if they were healthy. The market mechanism here is simple and cruel. Fantasy prices anchor to ADP — the average position at which a player is drafted. ADP doesn't reflect the truth; it reflects collective belief. When a name gets pushed up early, the next person sees it as "safe" and pushes it higher. Belief feeds itself. I have seen this loop enough times to know where it ends: in a season where people sit watching their player in a t-shirt on the bench. I once spent an entire season in a courtside seat just to count how many times a player walked out of the locker room with an unusual gait. That experience taught me that a medical slip and a real body are two different things. One says "permitted." The other says "can bear it." The core: seven slips, seven risk levels The most trustworthy name in the group is Tyrese Haliburton. He tore his Achilles in Game 7 of the 2026 NBA Finals, one of the most severe injuries in Finals history, but he is only about 26 now — the age at which modern sports medicine yields its best recovery rates. He has three straight Top-14 finishes, a floor of 22nd, and his "floor general" role in Indiana is essentially unchanged. And he said it himself: "No restrictions. I'm the source." Haliburton is the highest-confidence asset in the group: youngest, best rank floor, clearest role. He is the only name where the story matches the foundation. The riskiest name is Damian Lillard. Age 36, returning from an Achilles tear, and he had already missed 112 games over the previous four seasons. He returns to Portland — a team that made the playoffs without him. Age plus Achilles plus an injury history is the worst formula in the entire piece. With Lillard, the discipline is to wait, not to buy in the middle rounds. Even the original analysis advised waiting until late rounds, and this time I agree with that caution, though I rarely agree with anyone. Ja Morant is a trap wrapped like a bargain. He is 27, with a Top-100 floor and a Top-50 ceiling, at an 8th-round price. At a glance, that's cheap. But he has played only 79 games over three seasons. If his true expected games land somewhere between 45 and 55, then that "Top-50 ceiling" loses most of its appeal. Morant is cheap on the price board, but expensive on the schedule board. Zach Edey is a statistical mirage. His "career highs across every category" come from... 11 games. Eleven games cannot forecast anything about an 82-game season. Not to mention Memphis has stacked Isaiah Stewart, Quinten Post and rookie Cameron Boozer into the frontcourt — a wall built precisely to cap his minutes. Edey has a sturdy floor but a ceiling locked by someone else's contract. When a team adds three big men in one summer, that signals replacement, not belief. Fred VanVleet returns from an ACL tear, and head coach Ime Udoka said it plainly: possible minutes restriction, and Steven Adams will not play back-to-backs. Houston now has Kevin Durant and Amen Thompson, who just signed a monster extension. VanVleet's usage will certainly drop. This is textbook load management: rule-compliant, but fantasy-damaging. A player on a minutes cap is a player on a points cap, and no talent compensates for minutes being cut. Walker Kessler is different. He missed 77 games with a shoulder injury, playing only 63 games over two seasons, but he has improved each year and is only about 25. His role in Los Angeles is unclear, and that is precisely the point to watch. Kessler is the only name in the group whose risk lies not in age but in role ambiguity. The contrarian angle The whole world is selling the "comeback" story. I see something else: these seven are judged by their pre-injury résumés, not by post-injury evidence. None of them has a single post-surgery sample to reference. All the data is old data. Irving's nine Top-20 seasons are nine seasons before the surgery. Haliburton's three Top-14 seasons are three seasons before the Achilles snapped. The empty summer of 2026 — the whole world slept, and I stayed up reading the fine print. I learned that the most valuable thing to read always sits in the small print, where people don't want you to look. Here, the small print is the absence numbers: 82, 82, 82, 62, 82, 71, 77. Read vertically, it tells a very different story from the headline. The headline says "coming back." The vertical column says "coming back from where." And there is a situation nobody wants to name: Portland. Lillard and Morant are two ball-dominant lead guards, both ball-addicted, both injury-prone, standing in the same backcourt. The team made the playoffs without either of them. How they share the ball "remains to be seen" — that line in the original is a very skillfully written confession. Insiders never say it out loud. They nod in the hallway, behind closed doors. And once two men both want the ball, the second one loses value — the only question is which one. Dallas is different. Irving returns to a team that has changed its centerpiece and now revolves around rookie Cooper Flagg. Flagg will siphon off some usage. Irving's past fit alongside Luka Doncic and LeBron James is a fine analogy, but an analogy is not a projection. A ball-hungry rookie plus an aging former star is a classic collision formula, and nobody has tested it. I'm not saying it will blow up. I'm saying it has never been tried. The key point the crowd misses is correlated risk. Two Achilles tears and two ACL tears in the same returning class. If the group underperforms as a block, anyone who drafted several names from this list absorbs non-diversifiable downside. This is systemic risk, not confined to individuals. And the fantasy market, which loves telling individual stories, almost never prices systemic risk. At 50, I'm finally old enough to say it straight: every deal is a planned escape. And every medical slip is a promise written in fading ink. Takeaway I'm not saying these seven will fail. I'm saying the market is paying for an unverified belief. Haliburton is the only name where the story and the foundation match. The rest need one condition: to be on the floor. The first twenty games will answer everything. If Haliburton holds 30 minutes a night, he confirms first-round value. If Portland has one clear ball-handler, the other's ceiling gets capped. If Edey drops below 20 minutes, the wall is built. If VanVleet keeps sitting, read that as a signal, not an accident. As for me, I keep my old habit: arrive at the facility at seven, stand in the third row, and look at the legs before looking at the name. The box score comes later. But that order — legs first, names second — is the only order worth trusting.